AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
U.S. FDA
North American Biologicals Inc. (NABI) announced that its QC-Hepatitis Quality Assurance Reagent for in vitro diagnostic use has been cleared for commercial distribution by the U.S. Food and Drug Administration (FDA).
QC-Hepatitis is the first multi-level, multi-constituent reagent cleared by the FDA to be used as an external control to promote the accuracy of hepatitis testing of the blood supply and blood products. In November 1991, NABI received FDA clearance of its QC-HIV Quality Assurance Reagent and will now be marketing both products to reference laboratories, blood bank laboratories and diagnostic product companies.
NABI …